Market Tracker

11/21 5:15pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

5.85
Delayed Data
As of 4:00pm ET
 +0.15 / +2.63%
Today’s Change
2.35
Today|||52-Week Range
8.25
+138.78%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close5.70
Today’s open5.70
Day’s range5.65 - 5.90
Volume184,949
Average volume (3 months)292,669
Market cap$313.8M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+81.94%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratioNM
Price/Sales87.21
Price/Book1.54

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.70+12.50%
DRRXDURECT Corp0.000.00%
CPRXCatalyst Pharmaceuti...+0.21+6.86%
PETXAratana Therapeutics...+0.05+0.74%
Data as of 4:00pm ET, 11/21/2017

Financials

Next reporting dateMarch 20, 2018
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts